| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000244265.1 |
Ponatinib |
Brain lower grade glioma |
0.039219115 |
Resistant |
| ENSG00000244265.1 |
Ponatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043995468 |
Resistant |
| ENSG00000244265.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.044428187 |
Sensitive |
| ENSG00000244265.1 |
Ponatinib |
Esophageal cancer |
0.007915679 |
Sensitive |
